GB0525540D0 - New treatment - Google Patents

New treatment

Info

Publication number
GB0525540D0
GB0525540D0 GBGB0525540.1A GB0525540A GB0525540D0 GB 0525540 D0 GB0525540 D0 GB 0525540D0 GB 0525540 A GB0525540 A GB 0525540A GB 0525540 D0 GB0525540 D0 GB 0525540D0
Authority
GB
United Kingdom
Prior art keywords
new treatment
treatment
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB0525540.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB0525540.1A priority Critical patent/GB0525540D0/en
Publication of GB0525540D0 publication Critical patent/GB0525540D0/en
Priority to PCT/GB2006/050457 priority patent/WO2007068983A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
GBGB0525540.1A 2005-12-15 2005-12-15 New treatment Pending GB0525540D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0525540.1A GB0525540D0 (en) 2005-12-15 2005-12-15 New treatment
PCT/GB2006/050457 WO2007068983A1 (en) 2005-12-15 2006-12-15 New treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0525540.1A GB0525540D0 (en) 2005-12-15 2005-12-15 New treatment

Publications (1)

Publication Number Publication Date
GB0525540D0 true GB0525540D0 (en) 2006-01-25

Family

ID=35736185

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0525540.1A Pending GB0525540D0 (en) 2005-12-15 2005-12-15 New treatment

Country Status (2)

Country Link
GB (1) GB0525540D0 (en)
WO (1) WO2007068983A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9649469B2 (en) 2008-04-24 2017-05-16 The Invention Science Fund I Llc Methods and systems for presenting a combination treatment
US9560967B2 (en) * 2008-04-24 2017-02-07 The Invention Science Fund I Llc Systems and apparatus for measuring a bioactive agent effect
US9449150B2 (en) 2008-04-24 2016-09-20 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US9282927B2 (en) 2008-04-24 2016-03-15 Invention Science Fund I, Llc Methods and systems for modifying bioactive agent use
US9662391B2 (en) 2008-04-24 2017-05-30 The Invention Science Fund I Llc Side effect ameliorating combination therapeutic products and systems
CN109816630B (en) * 2018-12-21 2020-09-04 中国人民解放军战略支援部队信息工程大学 fMRI visual coding model construction method based on transfer learning

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ514690A (en) * 1999-04-13 2004-07-30 Kenneth S Modulation of excitable tissue function by peripherally administered erythropoietin
WO2005084364A2 (en) * 2004-03-03 2005-09-15 The Kenneth S. Warren Institue, Inc. Long acting tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs

Also Published As

Publication number Publication date
WO2007068983A1 (en) 2007-06-21

Similar Documents

Publication Publication Date Title
HK1205935A1 (en) Non-lithotripsic kidney-stone therapy
GB0506759D0 (en) Combination treatment methods
EP1957413A4 (en) Sewage treatment
ZA200705459B (en) Treatment method
GB0624874D0 (en) Treatment
GB0600692D0 (en) Well treatment
GB0524103D0 (en) Healing
GB0504206D0 (en) Combination therapy
GB0509052D0 (en) Combination therapy
GB0516068D0 (en) Well treatment
GB2430002B (en) Well treatment
ZA200709627B (en) Combination therapy
GB0525540D0 (en) New treatment
GB0511769D0 (en) Treatment
GB0607952D0 (en) Novel treatment
GB0507003D0 (en) Therapeutic
GB0502171D0 (en) Well treatment
GB0426141D0 (en) Treatment
GB0424085D0 (en) Well treatment
GB0604460D0 (en) Treatment
GB0412411D0 (en) Treatment
GB0413584D0 (en) Well treatment
GB0500659D0 (en) Combination therapy
GB0514347D0 (en) Combination therapy
GB0506725D0 (en) Combination therapy